PLYX · Forms 3, 4, 5
Insider trades at Polaryx Therapeutics, Inc.
No open-market insider buys or sells at Polaryx Therapeutics, Inc. in the last 90 days; 9 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Polaryx Therapeutics, Inc. (PLYX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Polaryx Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Alex Keun Mo Yang | Chief Executive Officer | Buy | 88,453 | $4.07 | $360K | Form 4 | |
| G. Michael Landis | Chief Financial Officer | Buy | 2,867 | $2.79 | $8K | Form 4 | |
| Alex Keun Mo Yang | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| III Francis A Braun | Director | Became an insider (Form 3) | Form 3 | ||||
| Lisa Bollinger | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| G. Michael Landis | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Charles S. Ryan | Director | Became an insider (Form 3) | Form 3 | ||||
| Andrew John O | Chief Investment Officer | Became an insider (Form 3) | Form 3 | ||||
| Mitchel Berger | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.